SAYDON PHARAMACEUTICAL COMPANT in Pakistan.pptx

Pharmaceutical Company

1. A CASE STUDY BY SHAH KHALID

2. CONTENTS INFORMATION ABOUT PHARMA MARKET IN PAKISTAN SLOGAN , MISSION AND VISION OF THE COMPANY HISTORY OF THE COMPANY PRODUCTS CATEGORY AND PRODUCT NAMES PRODUCT QUALITY POLICY AND ASSURANCE MARKETING STRATEGY SALES STATISICS SWOT ANALYSIS RECOMENDATION

3. WHAT IS MEDICINE ? T he science or practice of the diagnosis, treatment, and prevention of disease (in technical use often taken to exclude surgery)

4. PAKISTAN PHARMACEUTICALS MARKET World Pharma Market Worth $300 Billion Pakistan Pharma Market Worth $6.4 Billion- 2% of World Total 30 MNCs and 400 national manufacturing Units are operating in Pakistan Share of MNC 45% Share of NCs is 55% Growth Rate 12% per annum

5. Top Companies in Pakistan GSK-GlaxoSmithKline Pfizer Abbott Novartis Sanofi -Aventis Roche Bayer Eli-Lilly Johnson & Johnson

6. Top National Companies Getz Sami Hilton Bosch Highnoon Macter Searle Wilson Saydon

7. SLOGAN, MISSION AND VISION OF VISION : WE are dedicated to achieve a leading position in Pakistan pharma market MISSION: is committed to improving the quality of human life by enabling people to do more, Feel them better and live a longer life SLOGAN: We are proud to provide quality medicines

8. History company was started by two real brothers and one 1 st cousin in april 1996 They were first running a business of medicine company on the name of LAHORE MEDICINE COMPANY AT the start they were manufacturing only 3 products Now they are manufacturing 121 products and have distributive channels in 38 cities Out of these 121 products they export 45 products to Afghanistan , Srilnaka and Burma Got ISO 9001:2000 Certificate in 2000 Operating in 38 major cities of the country In 2007 they merge with Roryan Pharma in 2007 for the purpose of increasing the sales and profit margin

9. MANAGEMENT CEO & Director Marketing Mr. Sayed Muhammad Tariq ( BA) Director Finance Mr. Sayed Muhammad Tahir ( MD) Managing Director Mr. Sayed abdur Rehman (Bsc) Marketing Manager Mr. Faiz Ullah (BBA) Marketing Operations Manager Mr. Nadeem Hassan (B.PHARM.MBA) Product Manager Mr. Shah Jahan ( B. pharm. M.phil) Quality Control Manager Mr. Feroz Shah ( Msc. Chemistry) Finance Manager Mr. Alam Zaib Khan ( MBA Finance)

10. PRODUCTS CATOGRIES Tablets, Dry Suspension Capsules , Injections Drops

11. PRODUCTS TO CONCERN CATEGORY Tablets, Capsules Drops Injections Dry suspension Exact PFX Riget Qindon Spox Moxidon AG- Drox ERI Ketor Saydazol Saydetron Volfen Riget Qindon Ceftop . GEO Cefwell Cefzar Sydocef Safme Sayzon Suloron Kimsay Tobradon AG- Drox Bsadox Azores No-Fung Ketonel Celadon OSYD Losyd Ul -Some Celecob Clara AG- Cin AG- Clor . Riget AG- Ceph Clara Azores Ridmal Ridmal . A-Sec AG- Cin AG-Fix

12. DISTRIBUTERS CITIES ABBOTABAD BAHAWALNAGAR BANNU, BAKKAR BURWALA, D.G. KHAN D.I. KHAN DIR, FAISALABAD GILGIT, JACOBABAD HYDERABAD JHUNG JHELUM KANDHKOT KANDIARO KASHMOR KOHAT,KASUR KOTLI, LAHORE LAYYAH

13. DISTRIBUTERS CITIES MARDAN MINGORA MIRPUR KHAS PESHAWAR MULTAN QUETTA R.Y. KHAN RAWALPINDI SARGODHA SHAHDADKOT , SHEIKHUPURA SUKKAR THULL T.T. SINGH TEMERGARA

14. PRODUCTS FOR CONCERN DISEASE QUINOLONES Antibiotic CEPHALOSPORINS Antibiotic TETRACYCLINES Antibiotic MACROLIDES Antibiotic AMINOGLYCOSIDES Antibiotic ANTI-TUBERCULOSIS Antibiotic ANTI-FUNGALS Antibiotic

15. PRODUCTS FOR CONCERN DISEASE ANTI-PROTOZOALS & ANTI-HELMINTICS Malaria & Leshmania SULPHONAMIDES &TRIMETHOPRIM Antibiotic ANALGESICS & ANTI-PYRETICS pain & fever MUSCLE RELAXANTS Spasm/ muscle pain ANTI-HAEMORRHAGIC Blood clotting ANTI-ULCERS peptic ulcer ANTI-MALARIALS Malaria

16. PRODUCTS FOR CONCERN DISEASE TRANQUILLISERS / SEDATIVES / HYPONOTICS fits/seizure/insomnia ANTI-DEPRESSENT depression ANTI-PSYCHOTICS psychotic disorder WATER FOR INJECTION sterile water CALCIUM & VITAMIN C multi vitamin

17. PRODUCT QUALITY ISO 9001:2000 Certificate in 2000 Saydon products are approved by DAR , USFDA Full compliance to Good Manufacturing Practice (GMP) and Good Laboratory Practice (GLP) Equipment, process and utilities validation Vendors auditing and approval (ISO certified) Standard Operating Procedures based on USFDA and EU guidelines. Continuous training and upgrading the knowledge of quality observance. Internal Audit of the plant Quality Assurance

18. PRODUCT QUALITY Quality Policy Manufacturing effective medicines in accordance with GMP.(Good Manufacturing Practice) Continuous improvements in human resources, processes and system through team effort and mutual respect. Customer satisfaction and ensuring the on time availability of quality medicines through strong marketing and distribution network.

19. PRODUCT QUALITY Quality Concept Manpower Machines Materials Environment Documentation

20. On Field Marketing One to one Detailing to HCPs by Medical Rep through When, Why, How Give Samples/starter packs to Drs Give Items of Medical Utility for promotion Participation in International and National Conferences Clinical Meetings Educational Programs for Drs. Sponsorship in Conferences and Seminars Economical Gifts like Pen, Torch, Tissue paper

21. Unethical Practices by Saydon Jewelry Furniture/Fixture Office Equipment Expensive Electronic Items Expensive Gifts Vacation Packages Local and Foreign Trips Renovation of Clinic Expensive Gifts Expensive Lunch/Dinner

22. MARKETING STRATEGY

23. Market Segmentation

24. Sales statistics of Saydon Half year sales Saydon sales in (millions Rupees) Roryan sales in (millions Rupees) Total sales of Saydon after merging with Roryan pharma in (millions Rupees) Total profit of Saydon pharma in (millions Rupees) Total profit percentage of Saydon pharma 1 jan-30 june 2003 60 60 12 20 1 july – 31 dec 2003 62 62 12.5 20 1 jan-30 june 2004 72 72 18 25 1 july – dec 31 2004 65 65 16.5 25 1 jan-30 june 2005 76 76 19 25 1 july-31 dec 2005 77 77 19.25 25 1 jan-30 june 2006 76 76 22.8 30 1 july- 31 dec 2006 80 80 24 30 1 jan -30 june 2007 70 23 93 18.6 20 1 july -31 dec 2007 72 25 97 19.4 20 1 jan-june 2008 70 23 93 18.6 20 1 july-31 dec 2008 70 25 95 19 20

25. TWO QUESTIONS WERED ASKED FROM THE MARKETING, FINANCE AND PRODUCTION MANAGERS Q 1: What was the reason that instead of making further investment in saydon pharma you preferred to make investment another pharmaceutical company of same status.? Q 2: Your profit from Roryan is not according to your expectation & satisfaction , would you like to make further investment for obtaining the required result?

26. STRENGTH Strong financial Position Strong distribution network Best research based NCs in Pakistan High Quality research Products according to GMP USFDA and ISO Top company in Antibiotic segments Enjoying customer’s faith Strong , Qualified, Trained Team

27. WEAKNESSES Beaurocratic Style of Management Lack of Strong Controlling System Limited Field Force in Specialty Groups Frequent Shortages of Products

28. OPPORTUNITY New research Molecules to be launched Manufacturing seasonal and stomach disease, syrups for different disease Globalization Emerging market of Vaccine Growth oriented FMCG Group like steroids

29. THREATS Uncertain rules and regulations of Govt. No Patent Law/protection in Pakistan Increasing Inflation and value of US-$ Increasing Competition by National Cos Large Field Force of National companies

30. RECOMMENDATION Identification of new products and assesses the market potential CSR activity Training of Sales field force. Conduct pre-launch studies and feasibility studies